通过分子级图形建模和子图形信息瓶,改进和可解释的细胞染色体P450介导代谢预测
Yi Li1, Qin-Wei Xu1, Guo-Lei Jian1
1College of Mathematics and Computer Science, Dali University, Dali 671003, China.
Journal of chemical information and modeling
|November 27, 2024
概括
GraphCySoM是一种新的图形神经网络模型,通过细胞染色体P450 (CYP) 酶准确预测药物代谢部位 (SoM). 这种可解释的方法提供了计算效率,并推动了药物发现.
科学领域:
- 计算化学是一种计算化学.
- 药物的发现和开发.
- 生物信息学是一种生物信息学.
背景情况:
- 准确预测由细胞P450 (CYP) 酶介导的药物代谢部位 (SoM) 对早期药物发现至关重要.
- 目前用于CYP介导SoM预测的计算方法面临挑战,包括原子级建模的局限性,复杂的特征工程以及缺乏药物化学可解释性.
研究的目的:
- 开发一种新的,可解释的分子级建模方法,用于预测由CYP介导的SoM.
- 通过利用图形神经网络和轻量级功能来克服现有的计算方法的局限性.
主要方法:
- 提出了GraphCySoM,这是一个基于图形神经网络 (GNN) 的分子级建模方法.
- 利用了轻质分子特征和可解释的亚结构注释.
- 集成的注意力机制和子图信息瓶,用于节点和特征重要性分析.
主要成果:
- 在CYP介导的SoM预测中,GraphCySoM显著超过了基线和竞争方法.
- 证明了卓越的性能与增强的计算效率.
- 通过可解释的分析,成功地确定了与SoM相关的子结构.
结论:
- GraphCySoM代表了一种新且有效的分子级建模方法,用于CYP介导的SoM预测.
- 该方法提供了最先进的性能,并提供了对药物代谢机制的潜在见解.
- 这项研究是第一个全面应用分子级建模和可解释技术到CYP介导的SoM预测的研究.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
30
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
30
Pharmacokinetic Models: Comparison and Selection Criterion
43
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
43
Pharmacokinetic Models: Overview
587
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
587
Mechanistic Models: Overview of Compartment Models
67
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
67
Drug Metabolism: Phase I Reactions
3.1K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
58
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
58


